Log In
Print this Print this

Ensituximab (NEO-102, NPC-1C)

  Manage Alerts
Collapse Summary General Information
Company Precision Biologics Inc.
DescriptionChimeric mAb targeting a variant of mucin 5AC oligomeric mucus/gel-forming (MUC5AC)
Molecular Target Mucin 5AC oligomeric mucus/gel-forming (MUC5AC)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today